Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial

Michael Böhm, Javed Butler, Andrew Coats, Lucas Lauder, Felix Mahfoud, Gerasimos Filippatos, João Pedro Ferreira, Stuart J Pocock, Martina Brueckmann, Sibylle J Hauske, Elke Schueler, Christoph Wanner, Subodh Verma, Faiez Zannad, Milton Packer, Stefan D Anker

Open source

DOI: 10.1093/eurheartj/ehae938
Published: 2025-03-04
Container: European Heart Journal
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehae938,
  title = {Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial},
  author = {Michael Böhm and Javed Butler and Andrew Coats and Lucas Lauder and Felix Mahfoud and Gerasimos Filippatos and João Pedro Ferreira and Stuart J Pocock and Martina Brueckmann and Sibylle J Hauske and Elke Schueler and Christoph Wanner and Subodh Verma and Faiez Zannad and Milton Packer and Stefan D Anker},
  year = {2025},
  journal = {European Heart Journal},
  doi = {10.1093/eurheartj/ehae938},
  url = {https://doi.org/10.1093/eurheartj/ehae938}
}

RIS

TY  - JOUR
TI  - Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
AU  - Michael Böhm
AU  - Javed Butler
AU  - Andrew Coats
AU  - Lucas Lauder
AU  - Felix Mahfoud
AU  - Gerasimos Filippatos
AU  - João Pedro Ferreira
AU  - Stuart J Pocock
AU  - Martina Brueckmann
AU  - Sibylle J Hauske
AU  - Elke Schueler
AU  - Christoph Wanner
AU  - Subodh Verma
AU  - Faiez Zannad
AU  - Milton Packer
AU  - Stefan D Anker
PY  - 2025
JO  - European Heart Journal
DO  - 10.1093/eurheartj/ehae938
UR  - https://doi.org/10.1093/eurheartj/ehae938
ER  -

APA

Böhm, M., Butler, J., Coats, A., Lauder, L., Mahfoud, F., Filippatos, G., Ferreira, J. P., Pocock, S. J., Brueckmann, M., Hauske, S. J., Schueler, E., Wanner, C., Verma, S., Zannad, F., Packer, M., & Anker, S. D. (2025). Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae938

Source records

crossref · retrieved 2026-09-26T20:51:54.576Z